Hospital Regional Alta Especialidad Bajio
León, Guanajuato, 37660, Mexico
NCT Number: NCT02414581
Clinical triple-blind randomized controlled trial to assess the use of two different mouthwashes to reduce the oral colonization by gramnegative bacteria in patients with chemotherapy
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Phase 3
León, Guanajuato, 37660, Mexico
Clinical triple-blind randomized controlled trial.
With two arms to the study:
GOAL. Assess whether there decrease in the rate of oral colonization by gram-negative bacteria in patients with chemotherapy by using chlorhexidine mouthwash.
SPECIFIC OBJECTIVES:
SECONDARY OBJECTIVES
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Mouth rinses with chlorhexidine 0.12%-based solution
Mouth rinses with Ethyl Alcohol 7%-based solution
Mouth rinses with chlorhexidine 2%-based solution
Time frame: 10 days
Time frame: Baseline
Time frame: 10 days
Time frame: 10 days
Hospital Regional de Alta Especialidad del Bajio
Other
Mouthwash With Chlorhexidine 0.12%/Ethyl Alcohol 7% Compared to Ethyl Alcohol 7% to Reduce the Rate Oral Colonization by Gram-negative Bacteria in Patients With Chemotherapy
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02231879
Agammaglobulinemia, Agranulocytosis
Bethesda, Maryland, United States
View Trial DetailsNCT07237906
Agranulocytosis, Arthritis
Istanbul, Turkey (Türkiye)
View Trial DetailsNCT04448301
Agranulocytosis, Cytopenia
Boston, Massachusetts, United States
View Trial DetailsNCT01916057
Agranulocytosis, Bacterial Infections and Mycoses
Paris, France
View Trial Details